Picture of Evotec SE logo

EVT Evotec SE Cashflow Statement

0.000.00%
de flag iconLast trade - 00:00
HealthcareSpeculativeMid CapFalling Star

Annual cashflow statement for Evotec SE, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line84.137.26.25216-176
Depreciation
Amortisation
Deferred Taxes
Non-Cash Items0.36424.323.9-165195
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital66.6-74.9-48.9-0.57694
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Taxes Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities15642.244.7122203
Capital Expenditures-27.9-31.9-99.1-119-181
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-11.3-54.7-56-125-234
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-39.1-86.6-155-244-416
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-77.8211246398-52.4
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash42168146277-284